CIZZLE BIOTECHNOLOGY HOLDINGS PLC (CIZ) — research page
UK · uk-cm-kg/LSE/CIZ · as of 2026-11-06
Identity and listing
The issuer is CIZZLE BIOTECHNOLOGY HOLDINGS PLC, listed on the LSE Main Market under ticker CIZ, with ISIN GB00BNG2VN02 and LEI 213800G3OS3SA2J1Y358. Its security type is Corporate, its segment is SSQ3, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | CIZZLE BIOTECHNOLOGY HOLDINGS PLC | source · 2026-11-06 |
| exchange | LSE Main Market | source · 2026-11-06 |
| ticker | CIZ | source · 2026-11-06 |
| ISIN | GB00BNG2VN02 | source · 2026-11-06 |
| LEI | 213800G3OS3SA2J1Y358 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | SSQ3 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | England and Wales (Companies House jurisdiction field) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 30 filings across 28 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8 days. The latest filing is dated 2026-11-02, is of type early_warning, and falls 4 days before the record date of 2026-11-06. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days across 892 issuers. In the sector Pharmaceuticals and Biotechnology [201030] the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 30 | 8 | 4 |
| exchange median: LSE Main Market (892 issuers) | 29 | 4 | 3 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | early_warning | Holding(s) in Company | |
| 2026-10-26 | regulatory_announcement | £500,000 Subscription, conversion of loan notes | |
| 2026-10-23 | regulatory_announcement | Cizzle presents at SYNLAB Innovation Symposium | |
| 2026-10-15 | regulatory_announcement | Update on Launch of Lung Cancer Test in USA | |
| 2026-10-13 | ch_capital | capital allotment shares — 2026-05-11 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is PKF Littlejohn LLP, with its location not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
For the elective professional client category the outcome is signal ACM-200 and is determinable. For the eligible counterparty category the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page as read.
Open research
One openly published research note is on the record, by Hardman & Co Life Sciences Research, dated 2021-05-14.
| date | publisher | note | kind |
|---|---|---|---|
| 2021-05-14 | Hardman & Co Life Sciences Research | Cizzle Biotechnology/BOULD — Initiation following re-admission | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
No issuer years are sealed. The market's vintage is not sealed, and no earliest sealed date is recorded. The live record began 2026-09-11. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CIZ (identity.isin)
- 10.3
- https://find-and-update.company-information.service.gov.uk/company/06133765 (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://www.londonstockexchange.com/stock/CIZ/cizzle-biotechnology-holdings-plc/company-page (identity.sector)
- 10.6
- https://mcp.uk-cm-kg.ai/events/LSE/CIZ (the disclosure lines)
- 10.7
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.8
- https://cizzlebiotechnology.com/wp-content/uploads/2025/03/Cizzle-Biotechnology-Holdings-PLC-Final-Annual-report-and-financial-statements-31-December-2023-Final-unsigned-29-April-2024.pdf (the auditor)
- 10.9
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.10
- https://cizzlebiotechnology.com/wp-content/uploads/2025/03/Cizzle-Biotech-Initiation-report-%E2%80%93-14-May-2021.pdf (open research)
- 10.11
- https://mcp.uk-cm-kg.ai/record/LSE/CIZ (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BNG2VN02"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:11fdd28ca36aa34e.